Synlait (ASX:SM1) share price crashes 7% on cancelled guidance

The Synlait (ASX:SM1) share price is sliding in early trade after the dairy producer withdrew its FY21 profit guidance. Here's the lowdown.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Synlait Milk Ltd (ASX: SM1) shares have opened sharply lower today after the New Zealand dairy processor announcing the cancellation of its full-year profit guidance for FY21. At the time of writing, the Synlait share price has slumped 7.24% to $3.33. 

Let's take a closer look at what Synlait announced.

baby with look of surprised as if at huge increase in COVID baby boom asx shares

Image source: Getty Images

What's impacting the Synlait share price?

The Synlait share price is on the slide after the company this morning provided a statement to the ASX advising the withdrawal of its FY21 guidance for the following reasons:

  1. Ongoing uncertainty surrounding demand from A2 Milk Company Ltd (ASX: A2M) for the remainder of FY21.
  2. The impact of this fall in demand on Synlait's production. According to the company, production of infant formula base powder will drop "significantly".
  3. Continued global shipping delays, which the company claims, "may still further impact the FY21 result."
  4. Commodity price volatility.

In further bad news for the Synlait share price, the company also proclaimed:

"The company's previous guidance, that the overall FY21 [net profit after tax] NPAT result will be approximately half that of the FY20 NPAT result, will now not be attainable."

Synlait is scheduled to release its half-year results on 29 March.

Synlait's relationship with A2 milk

In November 2019, A2 Milk and Synlait extended their supply agreement for an additional 2 years – ending in 2025.

Synlait is the producer of A2 Milk's signature product, its Platinum Infant Formula. The powdered dairy product is heavily sought after in China, with the daigou market acting as the main intermediary for the formula to reach the People's Republic.

The effects of COVID-19 and resulting border closures have wreaked havoc on daigou channels into Australia. As a result, demand for A2 Milk's baby powder plummeted.

Synlait describes A2 Milk as "a strategic partner". Additionally, A2 Milk is Synlait's second-biggest shareholder, owning nearly 20% of the company's shares.

Synlait and A2 Milk share price snapshot

Both the A2 Milk and Synlait share prices have taken a beating over the past year. A2 Milk shares have fallen by more than 43% over the past 52 weeks. In early trade today, the A2 Milk share price is trading 1.7% lower at $9.24.

Although not as steep, the Synlait share price has slumped by around 38% over the past year. 

Based on the current Synlait share price, the company has a market capitalisation of $784.7 million. Meanwhile, A2 Milk's market cap is $7 billion.

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A happy person clenching fists in celebration sitting at computer.
Broker Notes

Morgans says hold BHP shares and buy this ASX 200 stock      

Let's see what the broker is saying about these stocks this week.

Read more »

ASX share investor sitting with a laptop on a desk, pondering something.
Share Fallers

CSL shares crash to a 9-year low. Is it time to sell off my shares?

What's next for the beaten-down ASX biotech stock?

Read more »

An ASX 200 market analyst holds his hand to his chin and looks closely at his computer screens watching share price movements
Broker Notes

3 ASX 200 shares just upgraded to strong buy — here's what the brokers are saying

Do any of these ASX 200 stocks appeal to you?

Read more »

A disappointed man slumps in his chair and holds his head while playing an online game.
52-Week Lows

These 4 ASX 200 shares have slumped to fresh 52-week lows: Buy, sell or hold?

Should investors buy in the dip or sit on the sidelines?

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Beach Energy, Domino's, Origin Energy, and Pantoro Gold shares are dropping today

Why are these shares under pressure? Let's find out.

Read more »

A woman wearing a hard hat holds two sparking wires together as energy surges between them.
Share Market News

Origin Energy shares slump 10% this week: Buy, sell or hold?

The ASX energy company has hit some headwinds. How much longer can they continue?

Read more »

Person pressing the buy button on a smartphone.
Broker Notes

3 reasons to buy Pro Medicus shares today

A leading analyst believes Pro Medicus shares are now trading at a significant discount.

Read more »

Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
Broker Notes

Buy, hold, sell: Sigma Healthcare, Macquarie, Santos shares

Brokers reveal their latest ratings and reviews on 3 ASX 200 stocks.

Read more »